Sviluppa le abilità di trading
dai primi passi alle strategie avanzate
Nessuna carta di credito richiesta
Doc.ai Neuron News
| Nome | Prezzo | Limite di mercato | Volume | Cambio Titolare | Segnale | ||
|---|---|---|---|---|---|---|---|
|
Doc.ai Neuron
[NRN]
Cappuccio Mkt
-
Volume
$0
|
$0 | - | $0 NRN 0 |
0%
| Cambio Titolare | Segnale |
doc.ai @_doc_ai
.@AuthorityMgzine shares how @SharecareInc developed a new crowdsourced #machinelearning model to predict allergy… https://t.co/iPqRaAyWhF
doc.ai @_doc_ai
RT @sam_debrouwer: Our study at @SharecareInc (Former @_doc_ai ) "Environmental Allergies from Real World Data Through a Mobile Study Plat…
doc.ai @_doc_ai
RT @SharecareInc: And beyond the potential to predict and help prevent allergy symptoms, our Omix platform is designed to enable digital cl…
doc.ai @_doc_ai
RT @SharecareInc: Environmental allergies and their close relative, seasonal allergies, can make a huge impact on your day-to-day life. W…
doc.ai @_doc_ai
RT @sam_debrouwer: Our very own @akshaysharma, EVP of Artificial Intelligence at @SharecareInc , highlights advancements & impact of #feder…
doc.ai @_doc_ai
Today is #worldsleepday and we're excited to share that Dr. Tom Power at AIM Specialty Health has released a new co… https://t.co/Rnuu60nlWj
doc.ai @_doc_ai
Digital solutions powered by AI can protect people's privacy, augment care, and, in turn, help us enjoy healthier l… https://t.co/u1fIznMtiK
doc.ai @_doc_ai
Our clinical team frequently authors new protocols to help improve your patient relationship. Protocols in the Sere… https://t.co/1t8XnP5pez
doc.ai @_doc_ai
The Shareacare acquisition of https://t.co/NPpOtRSa2U is now complete. Head over to @SharecareInc to see how we're… https://t.co/QfHEgRKYps
doc.ai @_doc_ai
Serenity Builder, our web-based tool that empowers clinicians to build, deploy and measure clinical content is now… https://t.co/qSvrelQwQF